Metraipolis › archive › dc_27fd97f52ed7

Adherence to endocrine therapy and survival outcomes in hormone receptor-positive breast cancer — Europe PMC PMID:42147233

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42147233
DOI
10.3389/fonc.2026.1824288
License (as archived)
solo-consultazione
Archived
2026-10-07T20:34:20.015Z
SHA-256 of the archived text
a4ab225e84e68bb83004285be0b409310eececa3e556340c5faf32f185a30647
Stable URL of this page
https://metraipolis.com/documento/dc_27fd97f52ed7

How to cite

Adherence to endocrine therapy and survival outcomes in hormone receptor-positive breast cancer — Europe PMC PMID:42147233 — Europe PMC (en), https://europepmc.org/article/MED/42147233 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_27fd97f52ed7 (Metraipolis archive dc_27fd97f52ed7, sha256 a4ab225e84e68bb83004285be0b409310eececa3e556340c5faf32f185a30647)
BibTeX
@misc{dc27fd97f52ed7,
  title = {Adherence to endocrine therapy and survival outcomes in hormone receptor-positive breast cancer — Europe PMC PMID:42147233},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42147233},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_27fd97f52ed7; sha256 a4ab225e84e68bb83004285be0b409310eececa3e556340c5faf32f185a30647},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42147233. Agents can read the archived copy with the MCP tool read_document.